|
|
| Home | Featured Companies | Virtual Trading Game | Stock Market Blogs | Financial Tools | Investment | Sign Up & Play For Free | |
| Ariad Pharmaceuticals, Inc. | |
||||||||||||||||||||||||||||||||||||||||||||||||||||
| FREE SMALLCAP NEWSLETTER STARTING SOON - Sign Up Now | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ariad Pharmaceuticals, Inc. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ARIA | Last: $2.5799 ($+0.0799) | Volume: 680,246 | Last Trade: 5/16/2008 12:13:30 PM | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Today
Today | Last 7 Days | 1 Month | 3 Month | 6 Month | 1 Year |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ariad Pharmaceuticals, Inc. Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| ARIAD Pharmaceuticals is engaged in the discovery and development of medicines to treat cancers by regulating cell signaling with small molecules. As of Dec 31 2006, Co.'s lead cancer product candidate was AP23573, an inhibitor of the protein mammalian target of rapamycin, which appears to have a central function in cancer cells. Co.'s second product candidate, AP24534 , is an orally active kinase inhibitor which is in development for the treatment of chronic myeloid leukemia. In addition, Co. has a drug discovery program centered on small-molecule, molecularly targeted therapies and cell-signaling pathways implicated in cancer. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Ariad Pharmaceuticals, Inc. News & Press Releases | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ARIAD to Present Clinical Data at ASCO on the Anti-Tumor and Safety Profile of Its Oral Investigatio ARIAD Pharmaceuticals, Inc. ( ARIA ) today announced results of an open-label, Phase 1 multi-center, dose-ranging study of oral deforolimus, showing consistenc... [more] ARIAD to Webcast Presentation at the Lehman Brothers 11th Annual ... PR-Inside.com (Pressemitteilung): ARIAD to Webcast Presentation at the Lehman Brothers 11th Annual ... , Austria - Mar 17, 2008 www.ariad.com - ARIAD Pharmaceuticals, Inc. ( NASDAQ: ARIA ) today announced that it will present at the Lehman Brothers 11th Annual Global H Lehman Brothers 11th Annual Global Healthcare Conference Business Wire (press release): ARIAD Pharmaceuticals, Inc. ( NASDAQ: ARIA ) today announced that it will present at the Lehman Brothers 11 th Annual Global Healthcare ... ARIAD to Webcast Presentation at the Cowen and Company 28th Annual ... Ad-Hoc-News (Pressemitteilung): ARIAD to Webcast Presentation at the Cowen and Company 28th Annual ... , Germany - Mar 11, 2008 ARIAD Pharmaceuticals, Inc. ( NASDAQ: ARIA ) today announced that it will present at the Cowen and Company 28 th Annual Healthcare Conferen ARIAD to Webcast Presentation at the Ad-Hoc-News (Pressemitteilung): , Germany - Mar 11, 2008 ARIAD Pharmaceuticals, Inc. ( NASDAQ: ARIA ) today announced that it will present at the Cowen and Company 28 th Annual Healthcare Conference, being held at ... |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | Companies | Game | Blogs | Savings Calculator | Tools | Contact Us | Disclosure | Site Map | Sign Up | Copyright © 2008 SmallCapWatch, LLC. |
| Never invest based soley on information from this website or our e-mail and IM alerts | |
